Can Omicron stall the global recovery and cause economic uncertainty?

Team Veye | 28-Nov-2021 Omicron stall the global recovery

Several European nations detected their first cases of a highly infectious new coronavirus strain, as governments worldwide began pulling down the shutters to contain the new variant

The Technical Advisory Group on SARS-CoV-2 Virus Evolution met on 26 November 2021 to review what is known about the #COVID 19 variant B.1.1.529. WHO has named it Omicron and designated it a Variant of Concern.

The discovery of 'Omicron' last week has stirred concerns around the world that it could resist vaccinations and stretch the nearly two-year COVID-19 pandemic.

Two cases of the new variant of coronavirus were detected in Australia's Sydney. Each passenger came to Australia from southern Africa on November 27 and were presently in isolation. They were asymptomatic and fully vaccinated.

Governments around the world are struggling to stop the spread of Omicron, returning to stricter Covid guidelines and imposing travel restrictions on at-risk nations. Despite the banning of flights, there were increasing concerns that the variant had already been widely seeded around the world.

The economic impacts of this variant are already being felt. Flights between South Africa and Europe were being subject to quarantine or being shut down altogether. Airline stocks were quickly sold off,

Investors were uncertain whether the variant could potentially reverse months of progress at getting the COVID-19 pandemic under control. Anticipating more lockdowns and travel bans, they moved money into companies that largely benefited from previous wave.

Stocks sunk globally as the new variant raised fears of more economic impact with Wall Street’s VIX, a measure of its anxiety, rising 53.6% to 28.54, its highest since January before the vaccines began to be widely distributed. 

Disclaimer

Veye Pty Ltd(ABN 58 623 120 865), holds (AFSL No. 523157 ). All information provided by Veye Pty Ltd through its website, reports, and newsletters is general financial product advice only and should not be considered a personal recommendation to buy or sell any asset or security. Before acting on the advice, you should consider whether it’s appropriate to you, in light of your objectives, financial situation, or needs. You should look at the Product Disclosure Statement or other offer document associated with the security or product before making a decision on acquiring the security or product. You can refer to our Terms & Conditions and Financial Services Guide for more information. Any recommendation contained herein may not be suitable for all investors as it does not take into account your personal financial needs or investment objectives. Although Veye takes the utmost care to ensure accuracy of the content and that the information is gathered and processed from reliable resources, we strongly recommend that you seek professional advice from your financial advisor or stockbroker before making any investment decision based on any of our recommendations. All the information we share represents our views on the date of publishing as stocks are subject to real time changes and therefore may change without notice. Please remember that investments can go up and down and past performance is not necessarily indicative of future returns. We request our readers not to interpret our reports as direct recommendations. To the extent permitted by law, Veye Pty Ltd excludes all liability for any loss or damage arising from the use of this website and any information published (including any indirect or consequential loss, any data loss, or data corruption) (as mentioned on the website www.veye.com.au), and confirms that the employees and/or associates of Veye Pty Ltd do not hold positions in any of the financial products covered on the website on the date of publishing this report. Veye Pty Ltd hereby limits its liability, to the extent permitted by law to the resupply of services.

veye logo

Grab Your Free Report On 5 ASX Dividend Stocks To Buy In 2024

(+61)